Prostatic Neoplasms Clinical Trials in Seattle, Washington

5 studies are recruiting for prostatic neoplasms in Seattle, Washington right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

   Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC). Researchers have designed a study medicine called ifinatamab deruxtecan (also called I-DXd or MK-2400) to treat mCRPC. The goal of this study is to learn if people who receive I-DXd live longer ov…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   VA Puget Sound Health Care System ( Site 0054), Seattle, Washington

   Locations

   298 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT06925737 on ClinicalTrials.gov

2. Prostate Active Surveillance Study

   The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close monitoring of prostate cancer with the offer of treatment if there are changes in test results. This …

   Stage

   Not phased

   Ages

   21 and older

   Site

   Veterans Affairs Puget Sound Health Care System, Seattle, Washington

   Locations

   11 in total

   Run by

   University of Washington

   See if you can join NCT00756665 on ClinicalTrials.gov

3. A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

   The purpose of Parts 1, 2A, and 2B of the study is to determine the recommended regimen for Phase 2 (RP2Rs) of combination of JNJ-87189401 with JNJ-78278343 and the purpose of Part 2C of this study is to determine how safe the RP2R(s) of the combination of JNJ-87189401 and JNJ-78278343 is, with or …

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Swedish Medical Center, Seattle, Washington

   Locations

   19 in total

   Run by

   Janssen Research & Development, LLC

   See if you can join NCT06095089 on ClinicalTrials.gov

4. A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

   The purpose of this study is to identify the recommended phase 2 combination dose (RP2CD) of JNJ-78278343 in combination with JNJ-95298177 in Part 1 (Dose confirmation) of the study and to determine how safe and tolerable the RP2CD of JNJ-7827834 and JNJ-95298177 with or without JNJ-87189401 is for…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Fred Hutchinson Cancer Center, Seattle, Washington

   Locations

   6 in total

   Run by

   Janssen Research & Development, LLC

   See if you can join NCT07082920 on ClinicalTrials.gov

5. Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial

   The purpose of this study is to determine whether a 12-week, home-based, virtually supervised exercise program will slow cancer progression of prostate cancer among men with prostate cancer at high-risk of progression undergoing active surveillance. The name of the study intervention involved in th…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington

   Locations

   4 in total

   Run by

   Fred Hutchinson Cancer Center

   See if you can join NCT05918263 on ClinicalTrials.gov